Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank42
3Y CAGR-85.6%
5Y CAGR-10.5%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-85.6%/yr
Annual compound
5Y CAGR
-10.5%/yr
Recent deceleration
Percentile
P42
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00 | -94.2% |
| 2023 | 0.07 | +104.0% |
| 2022 | -1.83 | -226.6% |
| 2021 | 1.44 | +8222.6% |
| 2020 | 0.02 | +133.7% |
| 2019 | 0.01 | -99.0% |
| 2018 | 0.74 | - |
| 2017 | 0.00 | -100.0% |
| 2016 | 11.37 | +2575.0% |
| 2015 | 0.43 | - |